Literature DB >> 17529897

Bupropion interference with immunoassays for amphetamines and LSD.

Christian Vidal1, Thomas Skripuletz.   

Abstract

A 50-year-old male patient suddenly had lost consciousness, although he had previously been healthy. On arrival at hospital seizures arose. The authors investigated a urine sample of the patient, and performed toxicological drug screening with immunochemical Cloned Enzyme Donor Immunoassay (CEDIA) assays. Positive findings for amphetamines and LSD could not be confirmed. Using gas chromatography/mass spectrometry (GC/MS), and liquid chromatography/mass spectrometry (LC/MS), the authors identified bupropion, a drug used to aid in smoking cessation, as the interfering compound, which may cause false-positive results for amphetamines and LSD using the CEDIA assays.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17529897     DOI: 10.1097/FTD.0b013e318040adc3

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  2 in total

1.  Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay.

Authors:  Erica R Casey; Mitchell G Scott; Schirin Tang; Michael E Mullins
Journal:  J Med Toxicol       Date:  2011-06

2.  Urine drug screens: Considerations for the psychiatric pharmacist.

Authors:  G Lucy Wilkening; Genevieve M Hale; Clint Ross
Journal:  Ment Health Clin       Date:  2016-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.